Literature DB >> 19996592

Association of oxidative stress with realgar-induced differentiation in human leukemia HL-60 cells.

Li-Wen Wang1, Yan-Ling Shi, Nan Wang, Bao-Di Gou, Tian-Lan Zhang, Kui Wang.   

Abstract

BACKGROUND: Realgar (arsenic sulfide, As(4)S(4)) has been shown to have clinical efficacy in patients with newly diagnosed and relapsed acute promyelocytic leukemia. Mechanistic studies have demonstrated that realgar is able to induce cell differentiation.
METHODS: The oxidative stress in the realgar-induced differentiation was examined with human leukemia HL-60 cells. Cell differentiation was evaluated by the expression of cell surface antigen CD11b and nitroblue tetrazolium assay. The activities of catalase and superoxide dismutase were measured spectrophotometrically. Flow cytometry was used to assess cell cycle distribution and apoptosis, the cellular level of reactive oxygen species (ROS) and glutathione, as well as mitochondrial transmembrane potential (MTP).
RESULTS: The realgar-induced differentiation was enhanced by hydrogen peroxide, and preceded with drastic changes in ROS and catalase, as well as small changes in superoxide dismutase and the reduced form of glutathione. MTP values at 24 h were in linear proportion to the CD11b expression at 48 h when no apoptosis was observed.
CONCLUSION: Oxidative stress and stress-related MTP decrease are associated with realgar-induced differentiation in HL-60 cells. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19996592     DOI: 10.1159/000265528

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  4 in total

1.  Arsenic trioxide induces apoptosis of p53 null osteosarcoma MG63 cells through the inhibition of catalase.

Authors:  Yang Wang; Yudan Wei; Haiying Zhang; Yanfen Shi; Yulin Li; Ronggui Li
Journal:  Med Oncol       Date:  2011-02-10       Impact factor: 3.064

Review 2.  Arsenic in cancer treatment: challenges for application of realgar nanoparticles (a minireview).

Authors:  Peter Baláž; Ján Sedlák
Journal:  Toxins (Basel)       Date:  2010-06-21       Impact factor: 4.546

3.  Arsenic sulfide as a potential anti‑cancer drug.

Authors:  Wenping Ding; Lian Zhang; Sungkyoung Kim; Wei Tian; Yingying Tong; Jianwen Liu; Yong Ma; Siyu Chen
Journal:  Mol Med Rep       Date:  2014-11-03       Impact factor: 2.952

4.  The critical role of redox homeostasis in shikonin-induced HL-60 cell differentiation via unique modulation of the Nrf2/ARE pathway.

Authors:  Bo Zhang; Na Chen; Hongmei Chen; Zhenhua Wang; Qiusheng Zheng
Journal:  Oxid Med Cell Longev       Date:  2012-10-15       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.